glp 1 medullary thyroid cancer Do GLP-1s cause cancer? Here is the honest answer. The warning on these medications is about one rare type, thyroid cancer, and it traces back to rodent studies, not proven harm in GLP1-RA and thyroid cancers –

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), approved for diabetes and obesity, have shown promise in modulating reward-related brain pathways, suggesting potential benefits in the management of AUD

Start your weight loss journey with a consultation at Nervana Medical in Sandy, UT

Berberinefruit supports the health of the reproductive and urinary organs

Imagine a single therapy that targets both appetite regulation and glucose control, tirzepatide is turning that vision into reality

This course covers glucagon-like peptide-1 (GLP-1) receptor agonists for obesity and type 2 diabetes mellitus (T2DM)

Below are all of our articles for you to learn about GLP-1s!